Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Cellectis S.A. (NASDAQ: CLLS)
CLLS Stock Predictions and Ratings
WSX Rating:
SELL
WSX Forecast (1yr):
-2.90%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
37.50%
CLLS Stock Analysis
CLLS
PE Ratio:
CLLS
PEG Ratio:
Not Available
CLLS
Forward EPS Growth (12 month):
0.00%
CLLS
PS Ratio:
4.1
CLLS
PSG Ratio:
4.2
CLLS
Forward Revenue Growth (12 month):
1.00%
CLLS Articles
No data was found